570
Views
4
CrossRef citations to date
0
Altmetric
Research Papers

Tolerability of 2 doses of pandemic influenza vaccine (Focetria®) and of a prior dose of seasonal 2009-2010 influenza vaccination in the Netherlands

, , , &
Pages 1027-1032 | Received 02 Sep 2015, Accepted 10 Nov 2015, Published online: 22 Mar 2016

Figures & data

Table 1. Demographics of the study population.

Table 2. Numbers and frequencies of severities of local adverse events by sex. Differences between men and women are tested. Significant p-values are in bold.

Figure 1. Sex specific proportions (%) of systemic adverse events' after seasonal influenza vaccination and 2 doses of pandemic influenza vaccine.

Figure 1. Sex specific proportions (%) of systemic adverse events' after seasonal influenza vaccination and 2 doses of pandemic influenza vaccine.

Figure 2. Risk group specific proportions (%) of systemic adverse events' after seasonal influenza vaccination and 2 doses of pandemic influenza vaccine.

Figure 2. Risk group specific proportions (%) of systemic adverse events' after seasonal influenza vaccination and 2 doses of pandemic influenza vaccine.

Table 3. Number and frequencies of local and systemic adverse events by risk group and vaccination. Differences between risk groups are tested. Statistical significant p-values are in bold.

Table 4. Multivariable Generalized Linear Mixed Model analysis of the risk for local and systemic AEs after both pandemic doses with seasonal influenza vaccination set as reference, stratified by risk group.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.